​

Krystal Biotech Ownership | Who Owns Krystal Biotech?

OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary

Krystal Biotech is owned by 96.12% institutional investors, 11.84% insiders. Fmr is the largest institutional shareholder, holding 15.02% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.41% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKrystal Biotech96.12%11.84%-7.95%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.34M15.02%$766.40M
Blackrock3.95M13.95%$724.98M
Blackrock funding, inc. /de3.83M13.26%$676.84M
Vanguard group2.79M9.66%$492.91M
Avoro capital advisors2.78M9.61%$490.36M
State street1.40M4.83%$246.43M
Soleus capital management1.02M3.52%$179.85M
Capital world investors809.24K2.80%$142.86M
Frazier life sciences management688.46K2.38%$121.53M
Redmile group661.39K2.29%$116.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group661.39K11.36%$116.75M
Soleus capital management1.02M9.05%$179.85M
S squared109.22K7.33%$19.28M
Avoro capital advisors2.78M6.34%$490.36M
Frazier life sciences management688.46K3.64%$121.53M
Healthinvest partners ab42.19K2.93%$790.71K
Palisades investment partners41.39K2.87%$7.31M
Braidwell lp520.40K2.73%$91.87M
Evolutionary tree capital management12.46K2.40%$2.20M
Acuta capital partners10.57K1.93%$1.87M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Norges bank219.53K0.00%219.53K
Price t rowe associates inc /md/467.06K0.01%205.68K
Avoro capital advisors2.78M6.34%117.78K
Soleus capital management1.02M9.05%95.87K

Top Sellers

HolderShares% AssetsChange
Braidwell lp520.40K2.73%-207.41K
T. rowe price investment management---185.55K
Goldman sachs group348.25K0.01%-182.11K
Baker bros. advisors lp---169.93K
Lord, abbett---151.22K

New Positions

HolderShares% AssetsChangeValue
Norges bank219.53K0.00%219.53K$34.39M
Eagle asset management76.26K0.07%76.26K$13.90M
Perceptive advisors35.00K0.18%35.00K$6.18M
Ikarian capital24.42K0.44%24.42K$4.31M
Adar1 capital management18.52K0.31%18.52K$3.27M

Sold Out

HolderChange
Tfc financial management-1.00
Assetmark-1.00
Tradewinds capital management-1.00
Mendota financial group-2.00
Bokf, na-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252894.33%27,787,3363.78%961.12%1497.19%83-10.75%
Jun 30, 2025280-10.26%27,626,5581.12%951.06%140-8.50%94-16.07%
Mar 31, 20253109.54%27,310,084-1.64%941.01%15213.43%11112.12%
Dec 31, 2024175-41.28%17,639,222-37.00%610.65%85-45.51%63-31.52%
Sep 30, 202429716.47%27,997,874-1.68%970.98%156-9231.43%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology1.86M6.41%-
iShares Core S&P Small-Cap ETF1.51M5.23%-
Fidelity Growth Compy Commingled Pl S964.96K3.33%1.30K
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
American Funds SMALLCAP World A886.71K3.07%-
Vanguard US Total Market Shares ETF824.72K2.86%704.00
Vanguard Total Stock Mkt Idx Inv818.09K2.83%-17.16K
Fidelity Growth Company Fund702.99K2.43%-4.21K
Vanguard Small Cap Index631.98K2.18%-3.60K
iShares Russell 2000 ETF596.22K2.06%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 04, 2025Krishnan Suma President, R&DSell$347.27K
Dec 04, 2025Krishnan Suma President, R&DSell$563.64K
Dec 04, 2025Krishnan Suma President, R&DSell$204.85K
Dec 04, 2025Krishnan Suma President, R&DSell$74.13K
Dec 04, 2025Krishnan Suma President, R&DSell$1.25M

Insider Transactions Trends

DateBuySell
2025 Q4-32
2025 Q3-30
2025 Q2--
2025 Q1-21
2024 Q4-34

KRYS Ownership FAQ

Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 96.12%, followed by 11.84% insiders and -7.96% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 45.22%, which Krystal Biotech exceeds.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.34M shares, 15.02%), Blackrock (3.95M shares, 13.95%), and Blackrock funding, inc. /de (3.83M shares, 13.26%). Together, they hold 42.23% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Redmile group is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 11.36% of its assets in 661.39K Krystal Biotech shares, valued at 116.75M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.41% of its total shares outstanding invested in 1.86M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools